These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 37254126)

  • 1. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
    He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
    J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing.
    Shi K; Li Y; Yang L; Zhang Z; Guo D; Zhang J; Lu Y
    FASEB J; 2022 Nov; 36(11):e22620. PubMed ID: 36260317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA sequencing reveals the MIF-ACKR3 receptor-ligand interaction between iCAFs and tumor cells in esophageal squamous cell carcinoma.
    Liang J; Lei K; Liang R; Huang J; Tan B; Lin H; Wang M
    Cell Signal; 2024 May; 117():111093. PubMed ID: 38336189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients.
    Zhang S; Zhang S; Ma X; Zhan J; Pan C; Zhang H; Xie X; Wen J; Xie X
    Front Cell Infect Microbiol; 2023; 13():1165790. PubMed ID: 37180444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Liu M; Li F; Liu B; Jian Y; Zhang D; Zhou H; Wang Y; Xu Z
    BMC Med Genomics; 2021 Mar; 14(1):75. PubMed ID: 33691689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
    Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
    Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
    Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of IDO1 in Tumor Microenvironment Significantly Predicts the Risk of Recurrence/Distant Metastasis for Patients With Esophageal Squamous Cell Carcinoma.
    Qiu C; Lin Q; Ji S; Han C; Yang Q
    Lab Invest; 2023 Dec; 103(12):100263. PubMed ID: 37839637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Kaneta A; Saito K; Katagata M; Okayama H; Saito M; Saze Z; Watanabe Y; Hanayama H; Tada T; Sakamoto W; Momma T; Ohira H; Kono K
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):957-971. PubMed ID: 36368436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.
    Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y
    World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal fibroblasts are predictors of disease-related mortality in esophageal squamous cell carcinoma.
    Saito S; Morishima K; Ui T; Matsubara D; Tamura T; Oguni S; Hosoya Y; Sata N; Lefor AT; Yasuda Y; Niki T
    Oncol Rep; 2014 Jul; 32(1):348-54. PubMed ID: 24859885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
    Front Immunol; 2022; 13():918154. PubMed ID: 35880180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.